From: Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases
 | Name | up/down regulation | Description | model | Ref |
---|---|---|---|---|---|
lncRNA | HAR1F, HAR1R | down | HAR1F and HAR1R are direct targets of REST. Leading to thr repression of several important neuronal genes. | human HD brain_striatum | [23] |
DGCR5 | down | DGCR5 is a REST target lncRNA, which plays an important transcriptional regulatory role in HD | human HD brain | [24] | |
MEG3 | down | MEG3 is a direct target of REST and found in the chromatin compartment of the cell in association with PRC2 complex | human HD brain | ||
MEG3, NEAT1 | up | Loss of function of Meg3 and Neat1 modulated mHtt aggregates and downregulation of the Tp53 expression | R6/2 mouse cortex | [27] | |
NEAT1-L, NEAT1-S | up | NEAT1 provides neuroprotection against mHtt-induced cytotoxicity (NEAT1-L) and oxidative stress-induced injury (NEAT1-S). | R6/2 mouse brain | ||
TUG1 | up | TUG1 is a direct downstream target of p53 and could modulate mHTT-induced cytotoxicity by p53 activation. TUG1 could be able to binding to the PRC2 epigenetic regulatory complex. | human HD brain | [30] | |
TUNA | down | TUNA expression was associated with pathological disease severity, decreasing significantly as the disease grade increased. | human HD brain_caudate nucleus | [31] | |
LINC00341 | up | unknown | human HD brain | [25] | |
RPS20P22 | up | RPS20P22 regulates RPS20, which decreases will lead to accumulation of p53. | human HD brain | [25] | |
LINC00342 | down | unknown | human HD brain | [25] | |
NATs | Abhd11-os | down | Abhd11-os (called Abhd11-AS1 in human) attenuate the mHtt-induced tocixity and contribute to striatal vulnerability in HD. | R6/2 mouse model | [32] |
HTTAS_v1 | down | HttAS-v1 reduces endogenous mHtt tanscript level through RISC-dependent miR-like mechanism | human HD brain_frontal cortex | [7] | |
BDNF-AS | Â | BDNF-AS was associated with the recruitment of polycomb repressive complex 2 (PRC2), which locally induces the trimethylation of histone H3K27 within the locus and in that way plays an important role in the development of HD. | Â | ||
others | sCAGs | up | sCAG significantly decreased HTT-mediated neuronal viability in an Ago2-dependent mechanism. | R6/2 mouse striatum; human HD brain | [35] |
miRNAs | miR-9* | down | miR-9* targets the components of the REST repressor complex, CoREST and modulating the neurotrophic genes expression. | HD patient | [26] |
miR-10b-5p | up | miR-10b-5p targets BDNF and correlated to aberrant polycomb repressive complex2 (PRC2) regulation. | HD brain_profrontal cortices | [36] | |
miR-22 | down | miR-22 was found to target HDAC4, Rcor1 (CoREST) and Rgs2 mRNA and achieve neuroprotection and inhibit neurodegeneration. | HD brain | [26] | |
miR-27a | down | miR-27a increases MDR-1 expression; miR-27a can decrease the mHtt aggregates possibly through MDR-1 modulation. | R6/2 mice | [37] | |
miR-34a-5p | down | miR-34a downregulated SIRT1 through binding the 3′ UTR of sirt1 mRNA. | R6/2 mice | [38] | |
miR-34b | up | miR-34b is a P53-regulated miRNA and the levels may influence mHTT cytoplasmic distribution and toxicity | HD patient, plasma | [39] | |
miR-214, miR-125b, miR-146a, miR-150 | down | miR-214, miR-150, miR-146a and miR-125b target both huamn HTT and mouse Htt. | STHdh(Q111)/Hdh(Q111) cells | [40] | |
miR-125b, miR-146a, miR-150 | down | miR-146a, miR-150 and miR-125b are decreased in striatum of R6/2 mice. miR-125b and miR-150 target p53, which in turn regulates RelA/NFkB and miR-146a expressions | STHdhQ111/HdhQ111 cells | [41] | |
miR-124 | down | Decreased miR-124 expression could increase CCNA2 and is involved in deregulation of cell cycle | STHdhQ111/HdhQ111 cells | [42] | |
miR-124a | down | The neuronal-specific miR-124 is dysregulated in HD tissues, probably as a result of increased repression by REST. | R6/2 mouse brain | [43] | |
miR-128a | down | miR-128a targets the 3′ UTR of HTT, Huntingtin Interaction Protein 1 (HIP1) and SP1. | Transgenic HD monkeys | [44] | |
miR132 | down | The level of miR-132 associated with Ago2. miR-132 supplementation produced symptomatic improvement of motor function and lifespan. | R6/2 mice | [45] | |
miR-212/miR-132 | down | miR-212/miR-132 clusters are significantly associated with CAG length and implicated in neuronal survival and shows strongest down-regulation in the striatum. | HD transgenic mice | [35] | |
miR-196a | up | miR-196a might improve mitochondrial function by the upregulation of CBP and PGC-1α to promote oxidation phosphorylation and reduce oxidative stress, which was consistent with the amelioration of cytotoxicity by miR-196a. | HD brain, striatum | [46] | |
miR-196a | up | The higher expression of RAN binding protein 10 (RANBP10) in the brains of HD transgenic mice and exacerbates neuronal morphology and intracellular transport. miR-196a suppress the expression of RANBP10 through binding to its 3’UTR. | HD transgenic mice brain | [47] | |
miR-196a | up | miR-196a decreased mHTT expression and pathological aggregates through alteration of several neuronal regulatory pathways including ubiquitin-proteasome systems, gliosis and cAMP response element-binding protein pathway. | HD-iPSC derived neurons | [48] | |
miR-19, miR-146a, miR-432 | down | The increase in the expressions of PCNA, CHEK1 and CCNA2 was found to be the result of decreased expressions of miR-432, miR-146a, and (miR-19a and miR-146a) respectively. Exogenous expressions of these miR-432 and miR-146a in HD cells rescued the abnormalities in cell cycle and apoptosis. | STHdh(Q111)/Hdh(Q111) cells | [43] |